ID

20356

Beskrivning

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Visit 5 (Month 12) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Länk

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Nyckelord

Versioner (1)
  1. 2017-02-21 2017-02-21 -
Uppladdad den

21 februari 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Engelsk

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulär  
Concomitant Medication
Beskrivning

Concomitant Medication

Alias
UMLS CUI-1
C2347852
1. Since visit 2, were any of the non-study medications listed below taken?
Beskrivning

Concomitant medication

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
If yes, please indicate which of the following were taken:
Beskrivning

If yes, please indicate which

Datatyp

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1524063
ACE Inhibitors
Beskrivning

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
2. Since visit 2, were any ACE inhibitors taken?
Beskrivning

ACE Inhibitors currently taken

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
If yes, please indicate which, and total daily dose:
Beskrivning

If yes

Datatyp

text

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
UMLS CUI [2]
C2348070
Restricted Concomitant Medication
Beskrivning

Restricted Concomitant Medication

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0443288
3. Have any restricted medications in the categories defined on the opposite page been taken since visit 2?
Beskrivning

Restricted medication taken

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
UMLS CUI [1,4]
C0443288
If yes, please indicate which category
Beskrivning

if yes

Datatyp

integer

Alias
UMLS CUI [1,1]
C0683312
UMLS CUI [1,2]
C2347852
UMLS CUI [1,3]
C0443288
Tillbaka till toppen

Similar models

Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant medication
Item
1. Since visit 2, were any of the non-study medications listed below taken?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
Item
If yes, please indicate which of the following were taken:
integer
C2347852 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes, please indicate which
Code List
If yes, please indicate which of the following were taken:
CL Item
Parental anticoagulants (Short term use)  (1)
CL Item
Oral anticoagulants (Short term use) (2)
CL Item
Nitrates (oral or topical) (3)
CL Item
Estrogen replacement without progesterone (4)
CL Item
Estrogen replacement with progesterone (5)
CL Item
Digitalis (6)
CL Item
Statins (7)
CL Item
Fibrates (8)
CL Item
Dilitazem/Verapamil (9)
CL Item
Other calcium channel blockers (10)
CL Item
Alpha-blocker (11)
CL Item
Direct vasodilators (12)
CL Item
Peripheral sympatholytic (13)
CL Item
Central sympatholytic (14)
CL Item
Alpha-beta blocker (15)
CL Item
Beta-blocker (16)
CL Item
Loop-active diuretics (17)
CL Item
Diuretics of thiazide type (18)
CL Item
Potassium-sparing diuretics (19)
CL Item
Insulin (20)
CL Item
Oral hypoglycemic agents (21)
CL Item
Specific Cox II inhibitors (22)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
2. Since visit 2, were any ACE inhibitors taken?
boolean
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes
Item
If yes, please indicate which, and total daily dose:
text
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C2348070 (UMLS CUI [2])
Item Group
Restricted Concomitant Medication
C2347852 (UMLS CUI-1)
C0443288 (UMLS CUI-2)
Restricted medication taken
Item
3. Have any restricted medications in the categories defined on the opposite page been taken since visit 2?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
C0443288 (UMLS CUI [1,4])
Item
If yes, please indicate which category
integer
C0683312 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0443288 (UMLS CUI [1,3])
if yes
Code List
If yes, please indicate which category
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
CL Item
6 (6)
CL Item
7 (7)
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial